The 1918 influenza killed approximately 50 million people in a few short years, and now, the
world is facing another pandemic. In December 2019, a novel coronavirus named severe …

The COVID‐19 pandemic is rapidly spreading, and health care systems are being
overwhelmed with the huge number of cases, with a good number of cases requiring …

In this paper, we raise the hypothesis that Methylene Blue may be a treatment option for
Corona Virus Disease of 2019 specially when combined with Non Steroid Anti-Inflammatory …

Aprotinin is a broad-spectrum inhibitor of human proteases that has been approved for the
treatment of bleeding in single coronary artery bypass surgery because of its potent …

COVID-19 represents the biggest health challenge. Although the mortality rate of COVID-19
is low, the high numbers of infected people and those with post-COVID-19 symptoms …

Angiotensin‐converting enzyme 2 (ACE2), a key enzyme in the renin–angiotensin system
(RAS), is expressed in various tissues and organs, including the central nervous system …

Biopharmaceuticals are subjected to very strict purity requirements to be marketed. At the
same time, peptides and other biomolecules are industrially synthesized through techniques …

SARS-CoV-2 was reported as the cause of coronavirus disease 2019 (COVID-19) in late
December 2019. According to sequencing and phylogenetic studies, the new virus belongs …

Proteases are produced and released in the mucosal cells of the respiratory tract and have
important physiological functions, for example, maintaining airway humidification to allow …

Purpose: The aim of the study is to evaluate the effect of metformin in complication
improvement of hospitalized patients with COVID-19. Methods: This was a randomized …